Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges

about

Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges

Item

http://www.wikidata.org/entity/Q58749820

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Anticoagulation for Stroke Pre ...... dence and Treatment Challenges

@en

Anticoagulation for Stroke Pre ...... dence and Treatment Challenges

@nl

type

Item

label

Anticoagulation for Stroke Pre ...... dence and Treatment Challenges

@en

Anticoagulation for Stroke Pre ...... dence and Treatment Challenges

@nl

prefLabel

Anticoagulation for Stroke Pre ...... dence and Treatment Challenges

@en

Anticoagulation for Stroke Pre ...... dence and Treatment Challenges

@nl

P1476

Anticoagulation for Stroke Pre ...... dence and Treatment Challenges

@en

P2093

Konstantinos C Siontis

http://www.w3.org/2001/XMLSchema#string

Xiaoxi Yao

http://www.w3.org/2001/XMLSchema#string

P2860

Patterns of frailty in older adults: comparing results from higher and lower income countries using the Survey of Health, Ageing and Retirement in Europe (SHARE) and the Study on Global AGEing and Adult Health (SAGE)

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Frailty in older adults: evidence for a phenotype

Independent predictors of stroke in patients with atrial fibrillation: a systematic review

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

P304

873-889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4070/KCJ.2018.0261

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Avi Sabbag

Peter A Noseworthy

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30238705

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

6158453

http://www.w3.org/2001/XMLSchema#string